Detalles de la búsqueda
1.
Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial.
Lancet Oncol;
25(3): 317-325, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38342115
2.
Multimodal prediction of neoadjuvant treatment outcome by serial FDG PET and MRI in women with locally advanced breast cancer.
Breast Cancer Res;
25(1): 138, 2023 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37946201
3.
The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 -) advanced/metastatic breast cancer.
Breast Cancer Res Treat;
197(2): 319-331, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36401732
4.
Fluorine-18-Labeled Fluoroestradiol PET/CT: Current Status, Gaps in Knowledge, and Controversies-AJR Expert Panel Narrative Review.
AJR Am J Roentgenol;
2023 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38117098
5.
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer.
N Engl J Med;
380(13): 1226-1234, 2019 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30917258
6.
Allogeneic hematopoietic cell transplantation in patients with a hematologic malignancy and a prior history of breast cancer.
Breast Cancer Res Treat;
194(3): 507-516, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35779160
7.
18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study.
Breast Cancer Res;
23(1): 88, 2021 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34425871
8.
Single arm, phase two study of low-dose metronomic eribulin in metastatic breast cancer.
Breast Cancer Res Treat;
188(1): 91-99, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33797651
9.
Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance).
Breast Cancer Res Treat;
188(2): 477-487, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33852121
10.
Whole-Body Characterization of Estrogen Receptor Status in Metastatic Breast Cancer with 16α-18F-Fluoro-17ß-Estradiol Positron Emission Tomography: Meta-Analysis and Recommendations for Integration into Clinical Applications.
Oncologist;
25(10): 835-844, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32374053
11.
A Pilot Study of a Comprehensive Financial Navigation Program in Patients With Cancer and Caregivers.
J Natl Compr Canc Netw;
18(10): 1366-1373, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33022646
12.
Adjuvant continuous metronomic adriamycin + cyclophosphamide followed by weekly nab-paclitaxel for high-risk early-stage breast cancer.
Breast J;
24(4): 610-614, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29532546
13.
Temporal Heterogeneity of Estrogen Receptor Expression in Bone-Dominant Breast Cancer: 18F-Fluoroestradiol PET Imaging Shows Return of ER Expression.
J Natl Compr Canc Netw;
14(2): 144-7, 2016 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26850484
14.
Satisfaction with cancer care among American Indian and Alaska Natives in Oregon and Washington State: a qualitative study of survivor and caregiver perspectives.
Support Care Cancer;
24(6): 2437-44, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26638004
15.
The use of stereotactic radiosurgery for brain metastases from breast cancer: who benefits most?
Breast Cancer Res Treat;
149(3): 743-9, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25638395
16.
Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial.
Lancet Oncol;
15(4): 474-82, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24636210
17.
Trends in 5-year survival rates among breast cancer patients by hormone receptor status and stage.
Breast Cancer Res Treat;
147(3): 609-16, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25164974
18.
Summary: SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16α-[18F]Fluoro-17ß-Estradiol PET.
J Nucl Med;
65(2): 221-223, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38071554
19.
Alcohol, Smoking, and Risks of Breast Cancer Recurrence and Mortality among Women with Luminal, Triple-Negative, and HER2-Overexpressing Breast Cancer.
Cancer Epidemiol Biomarkers Prev;
33(2): 288-297, 2024 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38019269
20.
Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials.
EJNMMI Res;
14(1): 32, 2024 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38536511